One of the major causes of hearing loss in mammals is damage to the sound-sensing hair cells in the inner ear. For years, scientists have thought that these cells are not replaced once they're lost, but new research appearing ...
Feb 20, 2014
1
3
(Medical Xpress)—Does your child or teen spend hours "plugged in" to an iPod? Tuning out may be doing more than irritating parents. It is estimated that almost 12 percent of all children between the ages of 6-19 have noise ...
Feb 20, 2014
1
1
Cancer patients could one day experience fewer side effects from chemotherapy following a discovery that opens the door for more targeted treatments.
Feb 13, 2014
0
0
If the content of many a situation comedy, not to mention late-night TV advertisements, is to be believed, there's an epidemic of balding men, and an intense desire to fix their follicular deficiencies.
Jan 28, 2014
0
0
(Medical Xpress)—Much of what is known about sensory touch and hearing cells is based on indirect observation. Scientists know that these exceptionally tiny cells are sensitive to changes in force and pressure. But to truly ...
Jan 8, 2014
0
0
Regenerative medicine may offer ways to banish baldness that don't involve toupees. The lab of USC scientist Krzysztof Kobielak, MD, PhD has published a trio of papers in the journals Stem Cells and the Proceedings of the ...
Dec 18, 2013
0
0
A pathway known for its role in regulating adult stem cells has been shown to be important for hair follicle proliferation, but contrary to previous studies, is not required within hair follicle stem cells for their survival, ...
Dec 5, 2013
0
0
Much of what is known about sensory touch and hearing cells is based on indirect observation. Scientists know that these exceptionally tiny cells are sensitive to changes in force and pressure. But to truly understand how ...
Dec 4, 2013
0
0
A key piece of the scientific model used for the past 30 years to help explain how humans perceive sound is wrong, according to a new study by researchers at the Stanford University School of Medicine.
Nov 20, 2013
1
0
In 2013 the European Medicines Agency approved the use of a new anti-cancer drug, Erivedge, developed by Genentech in collaboration with the Cambridge (Mass) based biotech company Curis Inc, for the treatment of Basal Cell ...
Nov 20, 2013
0
0
